Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Cell Mol Biol (Noisy-le-grand) ; 70(8): 121-128, 2024 Sep 08.
Artigo em Inglês | MEDLINE | ID: mdl-39262252

RESUMO

Congenital heart disease (CHD) is one of the most significant birth defects leading to infant mortality worldwide. Circulating microRNAs (miRNAs) are emerging as novel biomarkers for the detection of cardiovascular diseases. In this study, we aimed to investigate the role of maternal serum miRNAs expression as biomarkers in the diagnosis and prediction of children with CHD. High-throughput sequencing of peripheral blood from pregnant women with abnormal and normal fetal hearts identified 1939 differentially expressed miRNAs, the first 11 of which were selected as predictive biomarkers of CHD. The expression of miRNAs in more clinical samples was then quantitatively verified by reverse transcriptase polymerase chain reaction and the correlation between abnormal miRNAs and CHD was analyzed. Two miRNAs (hsa-miR-3195 and hsa-miR-122-5p) were found to be significantly down-regulated in pregnant women with fetal CHD. By further bioinformatics analysis, we predicted that hsa-miR-3195 and hsa-miR-122-5p could induce CHD by influencing biometabolic processes. hsa-miR-3195 and hsa-miR-122-5p may serve as novel non-invasive biomarkers for prenatal detection of fetal CHD.


Assuntos
Biomarcadores , Cardiopatias Congênitas , MicroRNAs , Humanos , Feminino , MicroRNAs/sangue , MicroRNAs/genética , Cardiopatias Congênitas/genética , Cardiopatias Congênitas/diagnóstico , Cardiopatias Congênitas/sangue , Gravidez , Biomarcadores/sangue , Adulto , Diagnóstico Pré-Natal/métodos , Perfilação da Expressão Gênica/métodos , Biologia Computacional/métodos , Sequenciamento de Nucleotídeos em Larga Escala
2.
J Invertebr Pathol ; 198: 107934, 2023 06.
Artigo em Inglês | MEDLINE | ID: mdl-37169329

RESUMO

Temperature is an important abiotic factor influencing the survival and fitness of pathogens as well as their hosts. We investigated the effect of three temperatures (18 °C, 27 °C and 37 °C) on survival and performance of black soldier fly larvae (BSFL), Hermetia illucens L., upon infection by an entomopathogenic Gram-negative bacterium, Pseudomonas protegens Pf-5. The effect of different temperatures on pathogen fitness was investigated both in vivo and in vitro. Pathogen performance under exposure to the insect antimicrobial peptide cecropin was investigated at the three temperatures using radial-diffusion plate assays. Higher rearing temperatures resulted in higher larval survival, increased larval weight, and higher inhibitory activity of cecropin against P. protegens Pf-5. At higher temperature, bacterial growth, both in vivo and in vitro, was reduced, resulting in increased BSFL survival. These observations collectively indicate the important effect of rearing temperature on host-pathogen interactions and the possibility to apply temperature treatment in reducing entomopathogen effects in BSFL.


Assuntos
Cecropinas , Dípteros , Animais , Temperatura , Larva , Interações Hospedeiro-Patógeno
3.
Macromol Biosci ; 24(7): e2400009, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-38490190

RESUMO

Taxol is one of the most widely used chemotherapeutic agents but is restricted by its poor solubility and severe side effects in clinical practice. To overcome these limitations, pH-sensitive nanoparticles, Acetalated Dextran6k-PEG5k-PLA2k-Taxol (ADPP-PTX), non-pH-sensitive nanoparticles, and Propionic Anhydride modified Dextran6k-PEG5k-PLA2k-Taxol (PDPP-PTX) are developed for the delivery of Taxol. Compared with PDPP-PTX, ADPP-PTX shows higher sensitivity to acid response and greater anti-proliferative effect on cancer cells. In the in vivo study, ADPP-PTX treatment effectively suppresses the growth of tumors, while only half the dose of Taxol is used, which significantly reduces systemic toxicity compared with Taxol and PDPP-PTX.


Assuntos
Nanopartículas , Paclitaxel , Paclitaxel/farmacologia , Paclitaxel/uso terapêutico , Paclitaxel/química , Concentração de Íons de Hidrogênio , Humanos , Animais , Nanopartículas/química , Camundongos , Antineoplásicos Fitogênicos/farmacologia , Antineoplásicos Fitogênicos/química , Antineoplásicos Fitogênicos/uso terapêutico , Feminino , Neoplasias/tratamento farmacológico , Neoplasias/patologia , Linhagem Celular Tumoral , Ensaios Antitumorais Modelo de Xenoenxerto , Polietilenoglicóis/química , Dextranos/química , Camundongos Nus , Proliferação de Células/efeitos dos fármacos , Camundongos Endogâmicos BALB C , Sistemas de Liberação de Fármacos por Nanopartículas/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA